GB0609588D0 - Nanoparticle Pharmaceutical Carrier - Google Patents

Nanoparticle Pharmaceutical Carrier

Info

Publication number
GB0609588D0
GB0609588D0 GBGB0609588.9A GB0609588A GB0609588D0 GB 0609588 D0 GB0609588 D0 GB 0609588D0 GB 0609588 A GB0609588 A GB 0609588A GB 0609588 D0 GB0609588 D0 GB 0609588D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical carrier
nanoparticle pharmaceutical
nanoparticle
carrier
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0609588.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HIKMA PHARMACEUTICALS Ltd
Queens University of Belfast
Original Assignee
HIKMA PHARMACEUTICALS Ltd
Queens University of Belfast
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HIKMA PHARMACEUTICALS Ltd, Queens University of Belfast filed Critical HIKMA PHARMACEUTICALS Ltd
Priority to GBGB0609588.9A priority Critical patent/GB0609588D0/en
Publication of GB0609588D0 publication Critical patent/GB0609588D0/en
Ceased legal-status Critical Current

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6925Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being a microcapsule, nanocapsule, microbubble or nanobubble
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1641Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647Polyesters, e.g. poly(lactide-co-glycolide)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
GBGB0609588.9A 2006-05-13 2006-05-13 Nanoparticle Pharmaceutical Carrier Ceased GB0609588D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GBGB0609588.9A GB0609588D0 (en) 2006-05-13 2006-05-13 Nanoparticle Pharmaceutical Carrier

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0609588.9A GB0609588D0 (en) 2006-05-13 2006-05-13 Nanoparticle Pharmaceutical Carrier

Publications (1)

Publication Number Publication Date
GB0609588D0 true GB0609588D0 (en) 2006-06-21

Family

ID=36637504

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0609588.9A Ceased GB0609588D0 (en) 2006-05-13 2006-05-13 Nanoparticle Pharmaceutical Carrier

Country Status (1)

Country Link
GB (1) GB0609588D0 (en)

Similar Documents

Publication Publication Date Title
IL194095A0 (en) Drug microparticles
GB0607866D0 (en) Nanostructures
PL2059558T4 (en) Novel nanoparticles
EP2057987A4 (en) Pharmaceutical composition containing statin-encapsulated nanoparticle
ZA200809546B (en) Pharmaceutical compounds
EP1992348A4 (en) Pharmaceutical combination
GB0608820D0 (en) Pharmaceutical compounds
EP2084279A4 (en) Dna-guided nanoparticle assemblies
EP1990052A4 (en) Pharmaceutical package
EP2038836A4 (en) Adverse drug reaction reduction
ZA200806318B (en) Drug combinations
IL197883A0 (en) Combination drug
GB0608184D0 (en) Pharmaceutical compounds
GB0608176D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
AP2734A (en) Pharmaceutical carrier composition and pharmaceutical composition
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0609588D0 (en) Nanoparticle Pharmaceutical Carrier
GB0622332D0 (en) Drug
ZA200902756B (en) Combination drug
GB0605952D0 (en) Carrier
AP2007004032A0 (en) Pharmaceutical carrier composition and pharmaceutical composition
IL195922A0 (en) Adverse drug reaction reduction

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)